PRF1 and Autoimmunity: Thus, the development of small drugs, such as dAbs, to bind targets within the IS, for example, perforin, may provide a approach to treat or alleviate diseases, such as autoimmunity, where cell-mediated cytotoxicity contributes to pathology.